Soriot
AstraZeneca’s Soriot Teva switch scotched
July 17, 2017Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical
The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …
AZ predicts strong growth ahead of Pfizer deadline
November 19, 2014Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens
AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …
AstraZeneca shores up defences against Pfizer
August 22, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger
AstraZeneca has been making a series of big deals over the past three months as it looks to close the …
Pfizer: ‘fewer scientists’ after merger
May 14, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover
Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …
Pfizer will ‘suck AZ’s lifeblood’
May 7, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, bbd, cable, merger
A former boss of AstraZeneca has warned that he fears Pfizer “will act like a praying mantis and suck the …
AstraZeneca ‘rejects Pfizer bid’
April 22, 2014Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger
AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …
AstraZeneca battling ‘headwinds’
February 7, 2014Sales and Marketing AstraZeneca, Soriot, farxiga, q4, results, xigduo
AstraZeneca is to shed another 550 jobs as its latest corporate restructure takes shape, bringing to 5,600 the number of …
AstraZeneca shakes up management
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot
AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …
Sharp fall for AstraZeneca
October 26, 2012Sales and Marketing AstraZeneca, Brennan, Q3, Soriot
AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
